为探究L-茶氨酸（L-theanine,LTA）对来曲唑诱导的多囊卵巢综合征（Polycystic ovarian syndrome,PCOS）大鼠临床症状的改善效果。将28只雌性SD大鼠按每组7只随机分为正常对照组、PCOS模型组、PCOS+低剂量LTA组和PCOS+高剂量LTA组。建模阶段,除正常对照组以生理盐水灌胃外,其余3组持续灌胃来曲唑28 d诱导PCOS模型。干预阶段,正常对照组和PCOS模型组以生理盐水持续灌胃,两个LTA干预组大鼠分别持续灌胃对应剂量LTA干预30 d。结果显示,与PCOS模型组相比,LTA干预组大鼠血清中睾酮（Testosterone,T）、黄体生成素（Luteinizing hormone,LH）、胰岛素（Insulin,INS）、甘油三酯（Triglyceride,TG）、总胆固醇（Total cholesterol,TC）、低密度脂蛋白（Low-density lipoprotein cholesterol,LDL-C）、脂多糖（Lipopolysaccharide,LPS）水平及胰岛素抵抗指数（HOMA-IR）均显著降低（P<0.05）,高密度脂蛋白（High-density lipoprotein cholesterol,HDL-C）水平均显著升高（P<0.05）,黄体生成素与卵泡刺激素的比值（LH/FSH）、空腹血糖（Fasting plasma glucose,FPG）和体重均有所下降（P>0.05）;低剂量LTA干预组大鼠血清雌二醇（Estradiol,E2）显著升高（P<0.05）;高剂量LTA干预组大鼠卵泡刺激素（Follicle stimulating hormone,FSH）显著升高（P<0.05）;LTA干预组大鼠的发情周期紊乱、卵巢组织多囊样病变较PCOS模型组均有一定程度的改善。结果表明,LTA干预能有效调节PCOS大鼠性激素分泌、恢复发情周期规律变化和改善其卵巢多囊样病变,同时显著改善PCOS大鼠胰岛素抵抗（Insulin resistance,IR）、血脂代谢紊乱并抑制异常水平的脂多糖（Lipopolysaccharide,LPS）分泌。
Abstract
To explore the improvement effect of L-theanine (LTA) on the clinical symptoms of letrozole-induced polycystic ovary syndrome (PCOS) rats, twenty-eight female SD rats were randomly divided into control group, PCOS group, PCOS+low-dose LTA group, and PCOS+high-dose LTA group with 7 rats in each group. In the modeling stage, except for the control group, the other three groups were administered letrozole continuously for 28 days to induce the PCOS model. During the intervention phase, the normal control group and the PCOS group were given continuous gastric administration with normal saline, and the rats in the two LTA groups were given continuous gastric administration with the corresponding dose of LTA intervention for 30 days. The results show that compared with the PCOS group, the serum testosterone (T), luteinizing hormone (LH), insulin (INS), triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), lipopolysaccharide (LPS) levels and homeostasis model assessment-insulin resistance (HOMA-IR) index in the LTA intervention group were significantly reduced (P<0.05), high-density lipoprotein cholesterol (HDL-C) was significantly increased (P<0.05), ratio of luteinizing hormone to follicle stimulating hormone (LH/FSH), fasting plasma glucose (FPG) and body weight were decreased (P>0.05). The serum estradiol (E2) of rats in the low-dose LTA intervention group was significantly increased (P<0.05). Follicle stimulating hormone (FSH) of mice in the high-dose LTA intervention group was significantly increased (P<0.05). At the same time, rat estrous cycle disorder and polycystic lesions of ovarian tissue were improved to a certain extent compared with PCOS group. The results show that LTA intervention can effectively regulate the secretion of sex hormones in PCOS rats, restore the regular changes of the estrus cycle, improve their ovarian polycystic lesions, and significantly improve insulin resistance (IR) and blood lipid metabolism disorders in PCOS rats and inhibit abnormal levels of lipopolysaccharide (LPS) secretion.
关键词
L-茶氨酸 /
多囊卵巢综合征 /
高雄激素血症 /
胰岛素抵抗
Key words
L-theanine /
hyperandrogenemia /
insulin resistance /
polycystic ovary syndrome
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Rao P, Bhide P.Controversies in the diagnosis of polycystic ovary syndrome[J]. Therapeutic Advances in Reproductive Health, 2020, 14: 1-11. doi: 10.1177/2633494120913032.
[2] Yang R, Yang S, Li R, et al.Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis[J]. Reprod Biol Endocrinol, 2016, 14(1): 67. doi: 10.1186/s12958-016-0203-8.
[3] Liu Q, Xie Y J, Qu L H, et al.Dyslipidemia involvement in the development of polycystic ovary syndrome[J]. Taiwanese Journal of Obstetrics & Gynecology, 2019, 58(4): 447-453.
[4] Jin P P, Xie Y Y.Treatment strategies for women with polycystic ovary syndrome[J]. Gynecol Endocrinol, 2018, 34(4): 272-277.
[5] Cunha A, Póvoa A M.Infertility management in women with polycystic ovary syndrome: a review[J]. Porto Biomed Journal, 2021, 6(1): e116. doi: 10.1097/j.pbj.0000000000000116.
[6] 刘杉, 李炜. L-茶氨酸药理作用的研究进展[J]. 神经药理学报, 2020, 10(2): 24-32.
Liu S, Li W.Research progress on pharmacological effects of L-theanine[J]. Acta Neuropharmacologica, 2020, 10(2): 24-32.
[7] 杨洲. 茶氨酸保健作用研究进展[J]. 茶叶通讯, 2018, 45(2): 3-7.
Yang Z.Research progress in the healthy functions of theanine[J]. Journal of Tea Communication, 2018, 45(2): 3-7.
[8] 彭彬, 刘仲华, 林勇, 等. L-茶氨酸改善慢性应激大鼠抑郁行为作用研究[J]. 茶叶科学, 2014, 34(4): 355-363.
Peng B, Liu Z H, Lin Y, et al.The ameliorative effect of L-theanine on chronic unpredictable mild stress-induced depression in rats[J]. Journal of Tea Science, 2014, 34(4): 355-363.
[9] 彭影琦, 肖文军, 张盛, 等. L-茶氨酸对小鼠肠道形态结构及游离氨基酸的影响[J]. 茶叶科学, 2019, 39(1): 43-54.
Peng Y Q, Xiao W J, Zhang S, et al.Effects of L-theanine on intestinal morphology and free amino acids in mice[J]. Journal of Tea Science, 2019, 39(1): 43-54.
[10] Xu W, Lin L, Liu A, et al.L-theanine affects intestinal mucosal immunity by regulating short-chain fatty acid metabolism under dietary fiber feeding[J]. Food & Function, 2020, 11(9): 8369-8379.
[11] 刘秋玲, 龚志华, 陈凌, 等. L-茶氨酸对产肠毒性大肠杆菌引起的免疫应激小鼠肝脏的保护作用研究[J]. 茶叶科学, 2016, 36(5): 484-490.
Liu Q L, Gong Z H, Chen L, et al.Study on the protective effect of L-theanine on the liver of mice with immune stress induced by ETEC[J]. Journal of Tea Science, 2016, 36(5): 484-490.
[12] 刘遵莹, 刘秋玲, 邓燕莉, 等. L-茶氨酸对产肠毒素大肠杆菌引起的免疫应激小鼠肠道的保护作用研究[J]. 茶叶科学, 2016, 36(5): 469-476.
Liu Z Y, Liu Q L, Deng Y L, et al.Study on the protective effect of L-Theanine on the intestinal in mice with immune stress induced by ETEC[J]. Journal of Tea Science, 2016, 36(5): 469-476.
[13] Lin L, Zeng L, Liu A, et al.L-Theanine regulates glucose, lipid, and protein metabolism via insulin and AMP-activated protein kinase signaling pathways[J]. Food & Function, 2020, 11(2): 1798-1809.
[14] Kafali H, Iriadam M, Ozardali I, et al.Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease[J]. Archives of Medical Research, 2004, 35(2): 103-108.
[15] 宋玉欣, 张娇, 贺麟, 等. L-茶氨酸对高蛋白饮食诱导大鼠行为变化的干预作用[J]. 食品科学, 2021, 42(5): 187-192.
Song Y X, Zhang J, He L, et al.Intervention effect of L-theanine on behavioral changes induced by high protein diet in rats[J]. Food Science, 2021, 42(5): 187-192.
[16] 曾立, 林玲, 彭影琦, 等. L-茶氨酸对D-半乳糖诱导衰老大鼠肝脏的晚期糖基化终末产物和炎性介质的影响[J]. 湖南农业大学学报(自然科学版), 2019, 45(6): 641-649.
Zeng L, Lin L, Peng Y Q, et al.Effect of L-theanine on AGEs and inflammatory mediators in the liver of D-galactose-induced senescence rats[J]. Journal of Hunan Agricultural University (Natural Sciences), 2019, 45(6): 641-649.
[17] 闫丽, 温和, 唐桂毅, 等. 大鼠阴道细胞涂片不同染色方法在动情周期判定中的价值[J]. 药物评价研究, 2020, 43(1): 72-76.
Yan L, Wen H, Tang G Y, et al.Diagnostic value of three staining methods for rat vaginal cell smears in determination of estrous cycle[J]. Drug Evaluation Research, 2020, 43(1): 72-76.
[18] 杨金姝. 羧甲基纤维素钠在食品工业中的应用研究[J]. 农产品加工, 2014(11): 76-78.
Yang J S.Application of sodium carboxymethyl cellulose in food industry[J]. Farm Products Processing, 2014(11): 76-78.
[19] Beydoun H A, Beydoun M A, Hossain S, et al.Patterns of bariatric surgeries among US women diagnosed with polycystic ovarian syndrome[J]. Journal of Women's Health, 2020, 29(4): 585-595.
[20] Dumesic D A, Akopians A L, Madrigal V K, et al.Hyperandrogenism accompanies increased Intra-abdominal fat storage in normal weight polycystic ovary syndrome women[J]. The Journal of Clinical Endocrinology & Metabolism, 2016, 101(11): 4178-4188.
[21] 虞希冲, 杨伟, 吴波拉. 茶氨酸经下丘脑腹外侧核抑制雌性小鼠摄食与胃排空作用研究[J]. 茶叶科学, 2013, 33(5): 429-435.
Yu X C, Yang W, Wu B L.Theanine depressed the food intake and gastric emptying in female mice via lateral hypothalamic AMPA and NMDA receptor[J]. Journal of Tea Science, 2013, 33(5): 429-435.
[22] 林玲. L-茶氨酸对糖、脂肪和蛋白质代谢的影响及机制[D]. 长沙: 湖南农业大学, 2019.
Lin L.Effects and mechanisms of L-theanine on metabolism of glucose, lipid and protein [D]. Changsha: Hunan Agricultural University, 2019.
[23] 胡伟. PCOS患者糖脂代谢异常及其与胰岛素抵抗的相关性分析[D]. 新乡: 新乡医学院, 2017.
Hu W.Abnormal glucose and lipid metabolism in PCOS patients and its correlation with insulin resistance [D]. Xinxiang : Xinxiang Medical College, 2017.
[24] Alissa E M, Algarni S A, Khaffji A J, et al.Role of inflammatory markers in polycystic ovaries syndrome: in relation to insulin resistance[J]. Journal of Obstetrics and Gynaecology Research, 2021, 47(4):1409-1415.
[25] Hattori K, Orisaka M, Fukuda S, et al.Luteinizing hormone facilitates antral follicular maturation and survival via thecal paracrine signaling in cattle[J]. Endocrinology, 2018, 159(6): 2337-2347.
[26] Gourgari E, Lodish M, Shamburek R, et al.Lipoprotein particles in adolescents and young women with PCOS provide insights into their cardiovascular risk[J]. The Journal of Clinical Endocrinology & Metabolism, 2015, 100(11): 4291-4298.
[27] 张美微, 侯丽辉, 李妍. 高雄激素血症与胰岛素抵抗对PCOS患者脂代谢的影响[J]. 河北医学, 2019, 25(10): 1690-1694.
Zhang M W, Hou L H, Li Y.Effects of hyperandrogenemia and insulin resistance on lipid metabolism in patients with PCOS[J]. Hebei Medicine, 2019, 25(10): 1690-1694.
[28] Liu R, Zhang C, Shi Y, et al.Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome[J]. Frontiers in Microbiology, 2017, 8: 324. doi: 10.3389/fmicb.2017.00324.
[29] Zhang J, Sun Z, Jiang S, et al.Probiotic bifidobacterium lactis V9regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain Axis[J]. mSystems, 2019, 4(2): e00017-e00019. doi: 10.1128/mSystems.00017-19.
[30] Hersoug L G, Møller P, Loft S.Gut microbiota-derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity[J]. Obesity Reviews, 2016, 17(4): 297-312.
[31] Yang W, Yu T, Huang X, et al.Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity[J]. Nature Communications, 2020, 11(1): 4457. doi: 10.1038/s41467-020-18262-6.
[32] Bertoldo M J, Caldwell A S L, Riepsamen A H, et al. A Hyperandrogenic environment causes Intrinsic defects that are detrimental to follicular dynamics in a PCOS mouse model[J]. Endocrinology, 2019, 160(3): 699-715.
[33] Dumesic D A, Oberfield S E, Stener-Victorin E, et al.Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome[J]. Endocrine Reviews, 2015, 36(5): 487-525.
[34] Dewailly D, Robin G, Peigne M, et al.Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary[J]. Human Reproduction Update, 2016, 22(6): 709-724.
[35] Cassar S, Misso M L, Hopkins W G, et al.Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies[J]. Human Reproduction, 2016, 31(11): 2619-2631.
[36] Moghetti P, Tosi F.Insulin resistance and PCOS: chicken or egg?[J]. Journal of Endocrinological Investigation, 2021, 44(2): 233-244.
基金
人社部“高层次留学人才回国资助计划”（人社厅函[2019]160号）、广西高等学校千名中青年骨干教师培育计划资助（桂教人[2018]18号）、广西高校中青年教师科研基础能力提升项目（2018KY0401）、桂林医学院引进人才科研启动基金（04010150001）、2020年国家级大学生创新创业训练计划项目（202010601031）
PDF(9844 KB)
浙公网安备 33019902000101号